Rothschild & Co Asset Management US’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FPF
JWA
AIM
Rothschild & Co Asset Management US's STJ Position: Q1 2017 in Review
Rothschild & Co Asset Management US sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,735 shares — an estimated $700K sold.
Rothschild & Co Asset Management US first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $31.2M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.
- Rothschild & Co Asset Management US reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
- Rothschild & Co Asset Management US sold 8,735 St Jude Medical shares in Q1 2017, an estimated $700K.
- Rothschild & Co Asset Management US first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
- Rothschild & Co Asset Management US's St Jude Medical position peaked at $31.2M in Q1 2014.
- 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.
Based on Rothschild & Co Asset Management US's 13F filing for Q1 2017, filed 12 May 2017.